Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Profession Legislation & policy, Terpene & residual solvent analysis, Pesticide analysis, Potency testing

Policy Précis

Epidiolex descheduled. For the first time, a cannabinoid medicine (Epidiolex, a CBD-based therapy used to treat Dravet syndrome) has been descheduled by the US DEA. Read the press release from manufacturer GW Pharma here.

EVALI leads to tighter cannabis controls. Oregon officials will carry out random testing for unlicensed additives in cannabis products and Washington State passed an emergency rule banning vape products containing vitamin E acetate. A second rule “requires manufacturers of THC products to disclose all compounds (including ingredients, solvents, additives, etc.) used in the production and processing as well as the sources of all vapor products."

Read the full article now

Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Charlotte Barker

Associate Content Director

After studying biology at Imperial College London, I got my start in biomedical publishing as a commissioning editor for healthcare journals, and I’ve spent my career covering everything from early-stage research to clinical medicine. Attracted by the creativity, talent and passion of the team, I joined Texere Publishing in 2014, where I’m now Associate Content Director and Editor of The Cannabis Scientist.

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register